Literature DB >> 19455364

Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report.

A Martínez-Ferrer1, P Peris, Ll Alós, M Morales-Ruiz, N Guañabens.   

Abstract

Primary hypertrophic osteoarthropathy, or pachydermoperiostosis (PDP), is an infrequent genetic condition characterized by digital clubbing, periostosis, and pachydermia and is distinct from a more common form, secondary hypertrophic osteoarthropathy, which always associates with an underlying cause (frequently pulmonary or cardiac disease). The diagnosis of this disorder as well as its clinical evaluation can be difficult. We report a 15-year-old boy presenting with intermittent arthralgias and clubbing of fingers and toes for the previous 2 years. The ankles and knees were enlarged, and X-rays showed periosteal apposition. The search for a secondary cause was negative. The skin appearance was normal, but a skin biopsy was indicative of pachydermia, further confirming the diagnosis of PDP. Bone turnover markers were increased at diagnosis and progressively decreased during follow-up; prostaglandin E(2), a recently implicated mediator of this disorder, was markedly elevated. In the present case, carrying out a skin biopsy helped us to diagnose this condition. In addition, bone turnover markers were useful for monitoring the disease activity; whereas, increased prostaglandin E(2) levels seems to confirm the role of this mediator in the etiopathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455364     DOI: 10.1007/s10067-009-1197-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Pachydermoperiostosis: an update.

Authors:  M Castori; L Sinibaldi; R Mingarelli; R S Lachman; D L Rimoin; B Dallapiccola
Journal:  Clin Genet       Date:  2005-12       Impact factor: 4.438

2.  Procollagen type I amino-terminal propeptide: pediatric reference data and relationship with procollagen type I carboxyl-terminal propeptide.

Authors:  Patricia M Crofton; Nancy Evans; Mervyn R H Taylor; Celia V Holland
Journal:  Clin Chem       Date:  2004-11       Impact factor: 8.327

3.  Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia.

Authors:  Aysenur Okten; Ilke Mungan; Mukaddes Kalyoncu; Zerrin Orbak
Journal:  Clin Rheumatol       Date:  2007-01       Impact factor: 2.980

4.  [Pachydermoperiostosis. A case report].

Authors:  F Kabi; O Mkinsi; S Janani; N Raissouni
Journal:  Rev Med Interne       Date:  2006-06-05       Impact factor: 0.728

Review 5.  Pediatric reference intervals for bone markers.

Authors:  Liju Yang; Vijaylaxmi Grey
Journal:  Clin Biochem       Date:  2006-01-19       Impact factor: 3.281

6.  99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.

Authors:  G Rubini; F Lauriero; D Rubini; A D'Addabbo
Journal:  Nucl Med Commun       Date:  1993-07       Impact factor: 1.690

7.  Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.

Authors:  Sandeep Uppal; Christine P Diggle; Ian M Carr; Colin W G Fishwick; Mushtaq Ahmed; Gamal H Ibrahim; Philip S Helliwell; Anna Latos-Bieleńska; Simon E V Phillips; Alexander F Markham; Christopher P Bennett; David T Bonthron
Journal:  Nat Genet       Date:  2008-05-25       Impact factor: 38.330

8.  Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis.

Authors:  D Rendina; G De Filippo; R Viceconti; E Soscia; C Sirignano; M Salvatore; M Della Monica; G Scarano; G Mossetti
Journal:  Scand J Rheumatol       Date:  2008 May-Jun       Impact factor: 3.641

9.  A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy.

Authors:  Hiroshi Jojima; Koichi Kinoshita; Masatoshi Naito
Journal:  Mod Rheumatol       Date:  2007-08-20       Impact factor: 3.023

10.  Unusual associations of pachydermoperiostosis: a case report.

Authors:  Uma Kumar; Surya Prakash Bhatt; Anoop Misra
Journal:  Indian J Med Sci       Date:  2008-02
View more
  5 in total

1.  A case report of disabling bone pain after long-term kidney transplantation.

Authors:  T M M Myint; M Vucak-Dzumhur; P R Ebeling; G J Elder
Journal:  Osteoporos Int       Date:  2013-06-26       Impact factor: 4.507

2.  The action of prostaglandins on ciliary hypertrichosis: a case report of pachydermoperiostosis.

Authors:  Fabiana P Zarur; Luiza Vf d'Almeida; Anna Beatriz C Novellino; Maria Fernanda Dg Reis
Journal:  Int J Trichology       Date:  2014-01

3.  Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

Authors:  Na Li; Yuhang Ma; Yun Jiang; Li You; Yunhong Huang; Yongde Peng; Xiaoying Ding; Li Zhao
Journal:  Int J Endocrinol       Date:  2020-12-03       Impact factor: 3.257

4.  Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.

Authors:  Sihoon Lee; So Young Park; Hyun Jin Kwon; Chul-Ho Lee; Ok-Hwa Kim; Yumie Rhee
Journal:  J Korean Med Sci       Date:  2016-03-22       Impact factor: 2.153

5.  Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial.

Authors:  Lu Yuan; Ruo-Xi Liao; Yuan-Yuan Lin; Yan Jiang; Ou Wang; Mei Li; Xiao-Ping Xing; Qian-Qian Pang; Evelyn Hsieh; Wei-Bo Xia
Journal:  J Orthop Translat       Date:  2018-10-31       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.